二氢嘧啶脱氢酶（DPD）检测必须仍是一种推荐的选择，但不是推荐的常规检测。 - Suppr

Suppr

超能文献

DPD testing must remain a recommended option, but not a recommended routine test.

作者信息

Milano G

机构信息

Centre Antoine-Lacassagne, Oncopharmacology Unit, UNS EA 3836, Nice, France.

出版信息

Ann Oncol. 2017 Jun 1;28(6):1399. doi: 10.1093/annonc/mdx118.

DOI:10.1093/annonc/mdx118

PMID:28327971

Abstract

摘要

相似文献

DPD testing must remain a recommended option, but not a recommended routine test.二氢嘧啶脱氢酶（DPD）检测必须仍是一种推荐的选择，但不是推荐的常规检测。

Ann Oncol. 2017 Jun 1;28(6):1399. doi: 10.1093/annonc/mdx118.

The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracil.尿嘧啶呼气试验在二氢嘧啶脱氢酶活性评估中的应用：呼出的13CO2与血浆[2-13C]二氢尿嘧啶之间的药代动力学关系

Clin Cancer Res. 2006 Jan 15;12(2):549-55. doi: 10.1158/1078-0432.CCR-05-2020.

Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio.预测5-氟尿嘧啶毒性：二氢嘧啶脱氢酶基因型与5,6-二氢尿嘧啶：尿嘧啶比率

Pharmacogenomics. 2014 Sep;15(13):1653-66. doi: 10.2217/pgs.14.126.

Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?常规检测二氢嘧啶脱氢酶以预测氟尿嘧啶相关严重毒性：炒作还是希望？

Clin Colorectal Cancer. 2010 Oct;9(4):224-8. doi: 10.3816/CCC.2010.n.033.

[Review of methods for determination of dihydropyrimidine dehydrogenase and possible application in screening previous chemotheraphy with 5-fluorouracil].[二氢嘧啶脱氢酶测定方法的综述及其在5-氟尿嘧啶既往化疗筛查中的可能应用]

Przegl Lek. 2012;69(9):694-7.

[Pro or con the phenotyping/genotyping of patients treated by 5-Fluorouracil to prevent adverse drug reactions?].[对于接受5-氟尿嘧啶治疗的患者进行表型/基因分型以预防药物不良反应，是支持还是反对？]

Therapie. 2007 Mar-Apr;62(2):105-9. doi: 10.2515/therapie:2007025. Epub 2007 Jun 21.

5-fluorouracil and dihydropyrimidine dehydrogenase.5-氟尿嘧啶与二氢嘧啶脱氢酶

Int J Clin Oncol. 2003 Jun;8(3):127-31. doi: 10.1007/s10147-003-0319-7.

Individualizing therapy with 5-fluorouracil related to dihydropyrimidine dehydrogenase: theory and limits.基于二氢嘧啶脱氢酶的5-氟尿嘧啶个体化治疗：理论与局限

Ther Drug Monit. 1996 Aug;18(4):335-40. doi: 10.1097/00007691-199608000-00004.

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?二氢嘧啶脱氢酶会影响基于5-氟尿嘧啶的治疗吗？

Eur J Cancer. 2000 Jan;36(1):37-42. doi: 10.1016/s0959-8049(99)00211-7.

5-Fluorouracil Chemotherapy for Dihydropyrimidine Dehydrogenase-deficient Patients: Potential of the Dose-escalation Method.二氢嘧啶脱氢酶缺乏患者的5-氟尿嘧啶化疗：剂量递增法的潜力

Anticancer Res. 2015 Sep;35(9):4881-7.

引用本文的文献

Uridine Triacetate for Severe Fluoropyrimidine Cardiotoxicity in a Patient With Thymidylate Synthase Gene Variants.尿苷三乙酸酯治疗胸苷酸合成酶基因变异患者的严重氟嘧啶心脏毒性

JACC CardioOncol. 2020 Jun 16;2(2):329-332. doi: 10.1016/j.jaccao.2020.04.005. eCollection 2020 Jun.

DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation.DPYD 和 UGT1A1 基因检测在胃肠道恶性肿瘤患者中的应用：证据概述及临床实施的考虑因素。

Pharmacotherapy. 2020 Nov;40(11):1108-1129. doi: 10.1002/phar.2463. Epub 2020 Oct 19.

and Fluorouracil-Based Chemotherapy: Mini Review and Case Report.以及基于氟尿嘧啶的化疗：综述与病例报告

Pharmaceutics. 2019 May 1;11(5):199. doi: 10.3390/pharmaceutics11050199.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验